Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Inwound ApS
APS
Active
Advertising protection
CVR 39766612
Herlufsholmvej 37, 2720
Vanløse
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
5 employees
http://www.inwound.com/
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Inwound ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LB
Lasse Blirup Snejbjerg
Chief Executive Officer
Chief Executive Officer
2026
Former (2)
JB
Janus Beierholm
Chief Executive Officer
Chief Executive Officer
2023 – 2026
SS
Sophia Sara Leth
Chief Executive Officer
Chief Executive Officer
2022 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
TD
Torsten Dahl Fredelund
Board of Directors
Board of Directors
2025
Bv
Bent von Eitzen
Board of Directors
Board of Directors
2025
CM
Carl Morten Bilbo
Chairman
Chairman
2026
CB
Christopher Bromley
Board of Directors
Board of Directors
2025
Former (6)
CI
Claus Ivan Rehfeld
Chairman
Chairman
2018 – 2023
SG
Søren Georg Jensen
Board of Directors
Board of Directors
2018 – 2019
SP
Sven Per Magnus Ågren
Board of Directors
Board of Directors
2018 – 2018
SJ
Simon Joshua Gabriel
Board of Directors
Board of Directors
2018 – 2018
BB
Bjørn Broby Glavind
Board of Directors
Board of Directors
2021 – 2022
HH
Helge Holm-Larsen
Board of Directors
Board of Directors
2019 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Akk Biotek Holding ApS
Company
50–66.65%
50–66.65%
2024
WINDING ROADS ApS
Company
10–14.99%
10–14.99%
2024
K Fischer Hansen ApS
Company
5–9.99%
5–9.99%
2024
InWound Invest ApS
Company
5–9.99%
5–9.99%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Inwound ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network